Alessandro Armuzzi

77PUBLICATIONS
242CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Italian language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Oct 25, 2026
Mirikizumab is associated with improvements in bowel urgency and quality of life in moderately-to-severely active ulcerative colitis: 28-week phase 3b results from the LUCENT-URGE trial.

|Oct 16, 2026
Beyond 'early surgery': Reframing Ileocaecal resection as strategic care in Crohn's disease.

|Oct 06, 2026
Targeting IL-23p19 in Inflammatory Bowel Disease: The Road Ahead.

|Sep 10, 2026
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

|Aug 08, 2026
Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression.

|Jul 27, 2026
Intestinal Ultrasound-Guided Precision Medicine in Inflammatory Bowel Diseases: A Narrative Review.

Pageof 13

Frequent Collaborators

21 joint publications

Arianna Dal Buono

18 joint publications

Cristina Bezzio

10 joint publications

Edoardo Vincenzo Savarino

8 joint publications

Daniela Pugliese